Alnylam Pharmaceuticals
ALNY
#626
Rank
S$43.33 B
Marketcap
$334.77
Share price
4.08%
Change (1 day)
69.83%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company